4.13
price up icon11.85%   0.46
after-market アフターアワーズ: 4.10 -0.03 -0.73%
loading
前日終値:
$3.67
開ける:
$3.69
24時間の取引高:
448.17K
Relative Volume:
0.64
時価総額:
$137.10M
収益:
-
当期純損益:
$-86.60M
株価収益率:
-1.4581
EPS:
-2.8324
ネットキャッシュフロー:
$-67.37M
1週間 パフォーマンス:
-1.08%
1か月 パフォーマンス:
-2.03%
6か月 パフォーマンス:
-26.43%
1年 パフォーマンス:
-65.18%
1日の値動き範囲:
Value
$3.60
$4.14
1週間の範囲:
Value
$3.60
$4.2664
52週間の値動き範囲:
Value
$1.45
$13.63

Lexeo Therapeutics Inc Stock (LXEO) Company Profile

Name
名前
Lexeo Therapeutics Inc
Name
セクター
Healthcare (1169)
Name
電話
(212) 547-9879
Name
住所
345 PARK AVENUE SOUTH, NEW YORK
Name
職員
75
Name
Twitter
Name
次回の収益日
2025-03-24
Name
最新のSEC提出書
Name
LXEO's Discussions on Twitter

LXEO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LXEO
Lexeo Therapeutics Inc
4.13 210.53M 0 -86.60M -67.37M -2.8324
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.62 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.09 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.98 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 31.91B 3.81B -644.79M -669.77M -6.24

Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-13 開始されました Robert W. Baird Outperform
2024-06-06 開始されました H.C. Wainwright Buy
2023-11-28 開始されました Chardan Capital Markets Buy
2023-11-28 開始されました JP Morgan Overweight
2023-11-28 開始されました Leerink Partners Outperform
2023-11-28 開始されました RBC Capital Mkts Outperform
2023-11-28 開始されました Stifel Buy
すべてを表示

Lexeo Therapeutics Inc (LXEO) 最新ニュース

pulisher
08:03 AM

Is Lexeo Therapeutics Inc. a good long term investmentExtraordinary profit generation - Autocar Professional

08:03 AM
pulisher
Jul 24, 2025

What risks could impact Lexeo Therapeutics Inc. stock performanceUnstoppable profit momentum - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Lexeo Therapeutics Inc. stock priceFree Stock Market Return Analysis - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Lexeo Therapeutics Inc. stockFree Daily Trading Room Entry - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Lexeo Therapeutics Inc. Stock Analysis and ForecastHigh-return market picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Will Lexeo Therapeutics Inc. stock split in the near futureSafe and Smart Investment Picks - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

Lexeo Therapeutics (NASDAQ:LXEO) & Organogenesis (NASDAQ:ORGO) Head to Head Analysis - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Lexeo Therapeutics Inc. stock outlookFree Investment Portfolio Suggestions - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

How high can Lexeo Therapeutics Inc. stock price go in 2025Safe and Smart Investment Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

What makes Lexeo Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

Why Lexeo Therapeutics Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Lexeo Therapeutics Inc. stock performs during market volatilityCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal - Investing.com

Jul 11, 2025
pulisher
Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics stock rises after FDA breakthrough designation By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Secures FDA Breakthrough Therapy Designation for LX2006, Shares Rise 8% in Pre-market Trade. - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics announces FDA Breakthrough Therapy Designation for LX2006 - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia Treatment - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

FDA grants breakthrough therapy designation to Lexeo’s FA treatment - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

FDA Breakthrough: Lexeo's Gene Therapy Shows Promise in Fatal Rare Disease Treatment - Stock Titan

Jul 07, 2025
pulisher
Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan | ATNFW SEC FilingForm 8-K - Stock Titan

Jul 01, 2025
pulisher
Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Lexeo Therapeutics stockholders elect directors and ratify auditor at annual meeting - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Lexeo Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 30, 2025

Lexeo Therapeutics Inc (LXEO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Lexeo Therapeutics Inc (LXEO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Adler Eric
Chief Medical Officer
May 16 '25
Sale
2.77
585
1,623
67,681
Robertson Jenny
Chief Legal Officer
May 16 '25
Sale
2.77
521
1,445
63,098
See Tai Sandi
Chief Development Officer
May 16 '25
Sale
2.77
367
1,018
59,242
$23.40
price down icon 1.00%
$36.67
price up icon 0.15%
$103.95
price up icon 0.34%
$28.67
price up icon 3.79%
$115.30
price up icon 0.53%
biotechnology ONC
$291.47
price down icon 1.79%
大文字化:     |  ボリューム (24 時間):